MAPT and Alzheimer disease: Necroptosis was exacerbated cognitive deficits in AD APP/PS1 mouse models, treatment with RIPK1 inhibitor Nec-1 reduced neuronal death and insoluble Aβ in cortex and hippocampus plaque and hyperphosphorylated tau formation and ameliorated cognitive impairment [199, 200].